New hope for Hard-to-Treat leukemia: drug cocktail shows promise
Disease control
Recruiting now
This study tests a new combination of three drugs (tagraxofusp, azacitidine, and venetoclax) for people with a type of acute myeloid leukemia (AML) that has come back or not responded to previous treatment. The goal is to see if this combination can help achieve remission. About …
Phase: PHASE2 • Sponsor: Joshua Zeidner • Aim: Disease control
Last updated May 10, 2026 05:23 UTC